Unisound has officially unveiled U2‑Med, an expert‑level large model that deeply integrates the full‑link scenarioses of medical care, medical insurance, and pharmaceuticals (including commercial insurance). This marks a critical leap for Unisound’s self‑developed U2 general foundation model — evolving from general‑purpose intelligence to specialized productivity within the vertical healthcare sector. Much like Anthropic’s foundation models that deliver striking performance in code generation, U2‑Med brings the powerful cognitive and reasoning capabilities of the U2 base model and adapts them perfectly to complex tri‑medical scenarioses.

Guided by the original aspiration of “AI for Good”, U2‑Med strives to upgrade AI from a conversational tool into a “digital expert” embedded in front‑line business workflows. By breaking down data and business silos across medical care, medical insurance and pharmaceuticals, and reconstructing the industrial ecosystem, U2‑Med is not only scaling new technical heights but also pursuing better human health outcomes. It leverages AI to drive medical services toward greater efficiency, equity and intelligence, so that the warmth of technology can truly benefit public health and well‑being worldwide.

01 Paradigm Shift: From General‑Purpose Dialogue to an Execution‑Oriented Expert for Tri‑Medical Collaboration

Over the past two years, while general large models possess broad knowledge, they often struggle with the stringent accuracy requirements and complex business logic of the healthcare industry — ending up as tools “only good for chatting but incapable of getting work done”. U2‑Med is built to address this core pain point.

Built upon Unisound’s self‑developed U2 general foundation model and ten‑year‑long expertise in the healthcare industry, U2‑Med delivers transformative advancement from cognition to execution. Far more than a generic Q&A chatbot, it features a system of over 70 callable and orchestratable professional skills. It can deeply interpret medical records, examination reports, billing documents and policy documents.

The model generates clear, traceable evidence chains for all outputs. It evolves beyond simple chat‑box interactions to serve as a neural hub for business workflows, acting as an intelligent foundation for coordinated tri‑medical operations.

02 Tri‑Medical Collaboration: Breaking Down Silos to Build a Closed‑Loop Full‑Domain Business Ecosystem

U2‑Med’s core strength lies in its cross‑domain linkage capability. Rather than simply stacking three separate domains, it unifies diagnosis‑treatment, payment and supply‑side workflows on one intelligent foundation to form efficient closed‑loop operations.

Medical Care End: Tireless "Super Clinical Brain"

Deeply embedded in full‑cycle hospital workflows, U2‑Med acts as physicians’ powerful external assistant. It automatically generates standardized smart medical records, freeing clinicians from heavy paperwork. It also identifies clinical documentation risks, functioning as a rigorous quality‑control specialist to proactively flag risks of missed diagnoses and medical errors. It drastically cuts administrative workload, enabling physicians to devote their full attention to core diagnosis and patient care.

Case: In‑depth Attribution and Panoramic Health Management for Complex Abnormal Physical‑Examination Results

Faced with dozens of complicated indicators including elevated liver enzymes, impaired glucose regulation and mixed dyslipidemia in a physical‑examination report, U2‑Med goes far beyond simple abnormal‑value alerts. It digs beneath raw data, categorizes anomalies into three core problem clusters linked to metabolic syndrome. Combined with the patient’s overweight status, it identifies potential risks of Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD). For a single low eGFR reading, the model prudently notes that chronic kidney disease cannot be diagnosed based on one test result. It automatically produces structured follow‑up plans including urine albumin‑to‑creatinine ratio re‑examination, glucose tolerance tests and overall cardiovascular risk assessment. U2‑Med turns fragmented lab values into high‑dimensional health insights, realizing the cognitive leap from data listing to clinical‑decision support.

Medical Insurance & Commercial Insurance End: Robust "Smart Gatekeeper"

Fully adapted to DRG/DIP payment reforms, U2‑Med serves as a round‑the‑clock fund gatekeeper. With powerful data insight capabilities, it processes massive volumes of documents to accurately spot compliance risks such as off‑specification medication, duplicate billing and excessive treatment. It completes intelligent preliminary review of all documents, filtering most routine risks. Human auditors can therefore focus on high‑risk investigations, striking a balance between cost control and service quality improvement.

Case: Cross‑Verification and Precise Interception of Off‑Label Medication Use

In the glypizide tablet review case, the model confirms medication administration facts. Through cross‑validation, it detects high‑risk patient conditions including acute myocardial infarction and renal insufficiency. It accurately concludes that the medication fails to meet medical‑insurance payment criteria, and provides complete evidence chains to help auditors prioritize high‑risk reviews.

Pharmaceutical End: Full‑Link Professional Guardian

Covering the full lifecycle of pharmaceuticals, U2‑Med acts as a powerful assistant for pharmaceutical enterprises in R&D and compliance management. It rapidly pre‑screens trial subjects for clinical trials, automatically verifies drug indications and contraindications, issues real‑time alerts for drug‑drug interaction risks, and intelligently structures dense drug‑package inserts. It supports R&D, pharmacovigilance and compliance workflows end‑to‑end, safeguarding safe launch and rational use of every drug.

Case: Logical‑Tree Decomposition and Accurate Matching for Complex Eligibility Criteria

In a clinical trial for laparoscopic or robotic inguinal hernia repair, the trial has strict inclusion criteria (unilateral and symptomatic hernias) and multiple exclusion criteria including minority status, emergency surgery and recurrent hernias. U2‑Med deeply parses electronic medical records of a 49‑year‑old male patient. It breaks down complex trial eligibility rules into executable verification logic trees, cross‑checking patient diagnoses, surgical plans and medical history. It effectively rules out risks such as bowel incarceration and confirms the patient meets trial‑enrollment requirements. The workflow compels hours‑long manual checking down to seconds, greatly boosting clinical‑recruitment efficiency and compliance.

03 AI for Good: Technology Empowerment to Safeguard Global Public Health

The tri‑medical linkage system built by U2‑Med means more than efficiency gains within individual links. It embodies profound care for human health and well‑being — the highest expression of “AI for Good”.

• Advance medical equity: Roll top‑tier clinical experience and quality‑control standards down to grassroots‑level settings, breaking geographic resource barriers and making high‑quality medical services more accessible and equitable.
• Strengthen safeguards for life: Protect medical‑insurance funds designated for critical healthcare needs, accelerate innovative‑drug R&D, and support human health comprehensively from payment guarantees to drug supply.
• Restore human‑centered doctor‑patient relationships: Relieve physicians of tedious mechanical work. Let technology handle computational tasks and let medical staff focus on human‑oriented care, rebuilding warm doctor‑patient interactions.

04 Authoritative Benchmark evalsuations: Double‑List Championship to Demonstrate Leading Performance

The value of large models lies in their real‑world capacity to solve complex professional‑domain problems. In the MedBench5.0 evalsuation released in July 2026, U2‑Med took first place on the core text track of the Agent evalsuation List for its outstanding logical‑reasoning performance. U2‑RadiMed, the medical multimodal large model built on U2‑Med’s text base coupled with vision encoder joint training, claimed top rank on the Multimodal Large‑Model evalsuation List.

In the Tri‑Medical Comprehensive Benchmark built with real‑world business scenarioses, U2‑Med achieves outstanding scores on core tasks: 93.3 points for medical‑record generation and quality control, 94.1 points for post‑diagnosis and medication management, and 95.5 points for safety and ethics.

These results prove U2‑Med can reliably translate general‑purpose foundational intelligence into vertical‑industry productivity, and its technical strengths translate directly into real‑world business value.

05 Broader Vision: From Tool‑level Replacement to Ecosystem Reconstruction

U2‑Med delivers far more than isolated efficiency improvements. It is paving the way for a brand‑new AI‑driven healthcare ecosystem.

• Evolving into digital infrastructure: Once deeply embedded in core medical‑care, medical‑insurance and pharmaceutical workflows, U2‑Med will function like power grids for industrial society — serving as foundational infrastructure for the AI‑powered healthcare era.
• Building a positive flywheel: High‑quality data accumulated from real‑world business operations continuously refine the model’s accuracy and intelligence. More institutions adopt the system, creating strong ecological moats.
• Pioneering the new paradigm of AI‑native healthcare: The future goes beyond “AI‑assisted healthcare”. It features full‑industrial‑chain reconstruction spanning new‑drug discovery, personalized diagnosis and treatment, and holistic medical‑insurance optimization. U2‑Med leads this new paradigm, exploring how AI can fundamentally improve human health outcomes.

U2‑Med is now live on Unisound Token Hub and open to individuals, developers and organizations. Experience it via: http://maas.ul800.com/models

When AI takes root in front‑line healthcare operations and upholds the original aspiration of “AI for Good”, it is more than an efficiency‑boosting tool. It becomes a cornerstone safeguarding human health and well‑being. Unisound marches forward toward this ambitious goal, accelerating the healthcare industry toward a more efficient, equitable and AGI‑enabled future. It ensures technological warmth and power benefit every patient and illuminates the future of human health.